Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
Completed
Conditions studied: Arterial Occlusive Diseases, Atherosclerosis, Coronary Disease, Cytomegalovirus Infections
In brief
The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in patients with and in patients without atherosclerosis is influenced by prior CMV exposure.
Key facts
- Study ID
- NCT00001531
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
- People needed
- 355
- Starts
- 1996-06-01
- Expected to finish
- 2000-09-01
- Last updated by the study team
- 2008-03-04
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- National Heart, Lung and Blood Institute (NHLBI) — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.